Danaher Corporation (DHR) is a global conglomerate that designs, manufactures and markets diverse lines of professional, medical, industrial, commercial and consumer products. The company organizes its businesses into five operating segments – The Test & Measurement segment, The Environmental segment, The Life Sciences & Diagnostics segment, The Dental segment and Industrial Technologies segment.
DHR’s top line has been benefitting from the performance of its operating culture – Danaher Business System. Also, management remains positive that optimizing the business portfolio will enable the company to capture lucrative growth opportunities.
Investors should also note the recent earnings estimate revisions for DHR, as the consensus estimate has remained flat in the last few months. Also, DHR has a decent history in earnings season, with a positive average earnings surprise of 0.58% in the last four trailing quarters.
Currently, DHR has a Zacks Rank #3 (Hold) but that could change following its first quarter 2015 earnings report which has just released. We have highlighted some of the key details from the just-released announcement below:
Earnings: Adjusted Earnings per share for the quarter came in at 93 cents, in line with the Zacks Consensus Estimate.
Revenue: Revenues of $4873.3 million surpassed the Zacks Consensus Estimate of $4847 million.
Key Stats: Strengthening of the U.S. dollar is likely to impact 2015 earnings adversely by reducing it $0.07 per share approximately.
Stock Price: Shares prices did not show any movement in the pre-market trading session.
Check back later for our full write up on this DHR earnings report later!
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment